The C10orf90 gene may serve as a marker for predicting the therapeutic efficacy of afatinib, ibrutinib, dabrafenib, vemurafenib, AICAR, and PLX4720 in patients with COAD. The gene discussed is C10orf90; the disease is colon adenocarcinoma.